Sajad Karampoor

3.3k total citations · 2 hit papers
72 papers, 2.5k citations indexed

About

Sajad Karampoor is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Sajad Karampoor has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 18 papers in Infectious Diseases and 18 papers in Immunology. Recurrent topics in Sajad Karampoor's work include MicroRNA in disease regulation (14 papers), COVID-19 Clinical Research Studies (13 papers) and Gut microbiota and health (12 papers). Sajad Karampoor is often cited by papers focused on MicroRNA in disease regulation (14 papers), COVID-19 Clinical Research Studies (13 papers) and Gut microbiota and health (12 papers). Sajad Karampoor collaborates with scholars based in Iran, Iraq and Russia. Sajad Karampoor's co-authors include Rasoul Mirzaei, Rasoul Yousefimashouf, Hossein Keyvani, Seyed Reza Hosseini‐Fard, Saba Jalalifar, Ali Teimoori, Behnaz Bouzari, Sima Kazemi, Farhad Zamani and Yaghoub Ahmadyousefi and has published in prestigious journals such as Frontiers in Microbiology, Journal of Cellular Physiology and International Journal of Biological Macromolecules.

In The Last Decade

Sajad Karampoor

71 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of microbiota-derived short-chain fatty acids in cancer development and prevention

2021 294 citations Rasoul Mirzaei, Sajad Karampoor et al. Biomedicine & Pharmacotherapy profile →
Role of microbiota-derived short-chain fatty acids in nervous system disorders

2021 290 citations Rasoul Mirzaei, Behnaz Bouzari et al. Biomedicine & Pharmacotherapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sajad Karampoor	1.3k	514	447	303	294	72	2.5k
Rasoul Mirzaei	1.4k 1.0×	568 1.1×	297 0.7×	279 0.9×	240 0.8×	79	2.5k
Léon Zheng	2.0k 1.5×	356 0.7×	345 0.8×	260 0.9×	227 0.8×	19	2.7k
Bejan Saeedi	1.7k 1.3×	431 0.8×	346 0.8×	325 1.1×	526 1.8×	41	3.0k
Wentao Ma	1.3k 1.0×	291 0.6×	304 0.7×	320 1.1×	447 1.5×	96	2.7k
Chuanxing Xiao	1.9k 1.4×	435 0.8×	214 0.5×	316 1.0×	152 0.5×	43	2.8k
Maureen Bower	1.4k 1.1×	403 0.8×	139 0.3×	544 1.8×	380 1.3×	8	2.2k
Zhuo‐Xun Wu	2.1k 1.6×	416 0.8×	367 0.8×	249 0.8×	192 0.7×	53	3.5k
Mariarosaria Boccellino	986 0.7×	334 0.6×	260 0.6×	299 1.0×	206 0.7×	96	2.7k
Jianzhong Hu	2.2k 1.6×	472 0.9×	133 0.3×	388 1.3×	468 1.6×	95	3.6k
Shakti D. Shukla	1.1k 0.8×	358 0.7×	130 0.3×	358 1.2×	224 0.8×	61	2.6k

Countries citing papers authored by Sajad Karampoor

Since Specialization

Citations

This map shows the geographic impact of Sajad Karampoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajad Karampoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajad Karampoor more than expected).

Fields of papers citing papers by Sajad Karampoor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sajad Karampoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajad Karampoor. The network helps show where Sajad Karampoor may publish in the future.

Co-authorship network of co-authors of Sajad Karampoor

This figure shows the co-authorship network connecting the top 25 collaborators of Sajad Karampoor. A scholar is included among the top collaborators of Sajad Karampoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajad Karampoor. Sajad Karampoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shahzamani, Kiana, et al.. (2025). Klotho protein: A key modulator of aging and COVID-19 severity. International Journal of Biological Macromolecules. 296. 139234–139234.

Hsu, Chou‐Yi, Lusine Khachatryan, Mohammed Ahmed Mustafa, et al.. (2024). Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection. Frontiers in Microbiology. 15. 1456793–1456793. 22 indexed citations

Bouzari, Behnaz, et al.. (2024). Immunometabolites in viral infections: Action mechanism and function. Journal of Medical Virology. 96(7). e29807–e29807. 1 indexed citations

Alameri, Ameer A., Rasha Fadhel Obaid, Jitendra Gupta, et al.. (2023). Metabolomic profiling of bacterial biofilm: trends, challenges, and an emerging antibiofilm target. World Journal of Microbiology and Biotechnology. 39(8). 212–212. 37 indexed citations

Zahednasab, Hamid, et al.. (2023). Exploring the role of tryptophanyl-tRNA synthetase and associations with inflammatory markers and clinical outcomes in COVID-19 patients: A case-control study. Microbial Pathogenesis. 183. 106300–106300. 1 indexed citations

Hjazi, Ahmed, Mohammed Alghamdi, Ali Kamil Kareem, et al.. (2023). Unraveling the impact of 27-hydroxycholesterol in autoimmune diseases: Exploring promising therapeutic approaches. Pathology - Research and Practice. 248. 154737–154737. 2 indexed citations

Al‐Gazally, Moaed E., Muhammad Imran, Andrés Alexis Ramírez‐Coronel, et al.. (2023). The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver. International Immunopharmacology. 123. 110713–110713. 13 indexed citations

Kazemi, Sima, Rasoul Mirzaei, Sajad Karampoor, et al.. (2023). Circular RNAs in tuberculosis: From mechanism of action to potential diagnostic biomarker. Microbial Pathogenesis. 185. 106459–106459. 4 indexed citations

Khachatryan, Lusine, et al.. (2023). Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review. Pathology - Research and Practice. 249. 154740–154740. 4 indexed citations

10.

Jalalifar, Saba, et al.. (2023). Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes. Infectious Agents and Cancer. 18(1). 3–3. 19 indexed citations

11.

Mirzaei, Rasoul, et al.. (2023). The emerging role of miRNA-122 in infectious diseases: Mechanisms and potential biomarkers. Pathology - Research and Practice. 249. 154725–154725. 17 indexed citations

12.

Tabibzadeh, Alireza, Mohammad Hadi Karbalaie Niya, Hossein Keyvani, et al.. (2022). Investigation of the Toll-like receptors expression profile in peripheral blood mononuclear cells in COVID-19 patients in Iran. Immunopathologia Persa. 9(2). 32405–32405. 1 indexed citations

13.

Alshahrani, Shadia Hamoud, Abduladheem Turki Jalil, Harun Achmad, et al.. (2022). Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism. Frontiers in Oncology. 12. 1042196–1042196. 14 indexed citations

14.

Jasim, Saade Abdalkareem, Hamzah H. Kzar, Irfan Ahmad, et al.. (2022). The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. International Immunopharmacology. 110. 109074–109074. 34 indexed citations

15.

Bouzari, Behnaz, et al.. (2022). Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis. Biomedicine & Pharmacotherapy. 148. 112760–112760. 25 indexed citations

16.

Shafaati, Maryam, Massoud Saidijam, Meysam Soleimani, et al.. (2021). A Brief Review on Dna Vaccines in the Era of COVID-19. Future Virology. 17(1). 49–66. 81 indexed citations

17.

Keyvani, Hossein, Hamid Zahednasab, Mohammad Sholeh, et al.. (2020). Gender Preponderance Might be Associated with the Severity of COVID-19 Infection. Journal of Clinical & Cellular Immunology. 11(5). 1–2. 3 indexed citations

18.

Karampoor, Sajad, et al.. (2020). Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis. International Immunopharmacology. 80. 106138–106138. 26 indexed citations

19.

Karampoor, Sajad, Hamid Zahednasab, Farah Bokharaei‐Salim, et al.. (2019). HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). International Immunopharmacology. 78. 105943–105943. 7 indexed citations

20.

Karampoor, Sajad, Hossein Keyvani, Farah Bokharaei‐Salim, et al.. (2018). The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod. Journal of Neuroimmunology. 328. 94–97. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact